A Public Health Notification issued by the FDA in October 2008 is prompting calls for a Bard Avaulta transvaginal surgical mesh recall. The Public Health Notification advised consumers and health practitioners about serious complications associated with transvaginal placement of surgical mesh used to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). Although the FDA reported having received more than 1,000 reports from nine surgical mesh manufacturers, including Bard Avaulta, of complications that were associated with these surgical mesh devices, no recall has been issued as of early 2009.

Bard Avaulta Surgical Mesh Recall Is Needed

Because no recall has been issued, many women continue to be implanted with Bard transvaginal surgical mesh. When these women experience complications, they are often unaware that the surgical mesh may be defective. Consequently, they may assume their health complications are unique and decline to have the mesh removed. A recall of the Bard surgical mesh would help avoid these problems.

Complications Prompting Bard Transvaginal Mesh Calls for Recall

The most common complications, which are prompting calls for a recall on Bard transvaginal surgical mesh products, include: pain, infection, urinary trouble, recurrence of prolapse and/or incontinence and erosion through the vaginal epithelium. Other complications related to transvaginal placement of Bard surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence prompting calls for a recall include discomfort and pain, including dyspareunia (pain during intercourse), from vaginal scarring and surgical mesh erosion. Transvaginal surgical mesh infections are serious complications that can be very damaging and painful to women who develop them.

Bard Transvaginal Surgical Mesh Recall Attorney

The attorneys at our law firm believe that Bard transvaginal surgical mesh is defective and should be recalled. Our attorneys believe a Bard transvaginal surgical mesh recall should be issued because our attorneys believe the defective mesh contributes to causing many of the side effects associated with transvaginal placement of Bard surgical mesh. For example, Bard transvaginal surgical mesh may inhibit surrounding tissue from receiving nutrients and oxygen, causing impaired healing, which can lead to other complications.

Although no Bard transvaginal surgical mesh recall has been issued as of early 2009, patients injured by defective Bard surgical mesh may be entitled to compensation for their injuries.

Confidential, Free and No Obilgation Bard Avaulta Mesh Lawsuit Consultation

If you or a loved one has experienced one of the serious complications associated with Bard transvaginal surgical mesh, contact us today for a confidential and free case evaluation. You may be able to file a Bard Avaulta mesh lawsuit.

Felecia Stern is one of our lawyers working with Bard Avaulta victims.  She can be reached privately at (877) 779-1414 (ext. 211) or by email at stern@bernlieb.com.

Related Bard Avaulta Articles

C.R. Bard Agrees to Settle Vaginal Mesh Lawsuit One Week after Plaintiff Awarded $2 Million in Similar Case
C.R. Bard Inc. has agreed to settle a vaginal mesh lawsuit filed by a woman who allegedly suffered permanent injuries caused by an implant from the company’s line of Avaulta pelvic mesh devices, Bloomberg.com reports. […] [Read More]
 
Second Bellwether Trial in C.R. Bard Vaginal Mesh Lawsuit Litigation Now Underway
The second bellwether trial in the federal C.R. Bard vaginal mesh lawsuit litigation began Monday in the Southern District of West Virginia, less than a week after the plaintiff in a similar case was awarded […] [Read More]
 
Plaintiff Awarded $2 Million in Federal C.R. Bard Vaginal Mesh Lawsuit
A West Virginia jury has awarded $2 million to a Georgia woman who sustained injuries stemming from C.R. Bard Inc.’s line of Avaulta mesh implants in the federal litigation’s first bellwether trial for a vaginal […] [Read More]
 
Closing Arguments Heard this Week in First Federal Trial for C.R. Bard Vaginal Mesh Lawsuit
Officials for C.R. Bard Inc. knowingly used a plastic considered unsuitable for human use when manufacturing some of its transvaginal mesh implants, attorneys argued this week in a federal litigation’s first bellwether trial for a […] [Read More]
 
C.R. Bard Mesh Lawsuit Heads to Trial, Ethicon Cases Move Forward in Federal Proceeding
Plaintiffs involved in mesh lawsuit claims watched with bated breath in July as the first federal bellwether case over a product from C.R. Bard Inc. headed to trial in the Southern District of West Virginia, […] [Read More]
 
First of 4,550 C.R. Bard Mesh Lawsuit Filings Heads to Trial July 29 in West Virginia Federal Court
The first trial for a federally-filed C.R. Bard mesh lawsuit is slated to begin today in the Southern District of West Virginia, where a jury will hear arguments from a public health nurse in Georgia […] [Read More]
 
Transvaginal Mesh Lawsuits, DePuy ASR Hip Recall Claims Head to Trial in 2013
Plaintiffs in transvaginal mesh lawsuits, as well as claims stemming from the DePuy ASR hip recall, will want to pay attention to some key trials scheduled to get underway in the new year.  The cases, […] [Read More]
 
Transvaginal Mesh Lawsuits Exceed 8,000
More than 8,000 transvaginal mesh lawsuits have now been filed against the makers of vaginal mesh used in surgery to treat pelvic organ prolapse and stress urinary incontinence. According to court records, Johnson & Johnson’s […] [Read More]
 
Massive Vaginal Mesh Class Action Filed In Australia
The transvaginal mesh class action underway in Australia against Johnson & Johnson may be the largest product class action in the country’s legal history. Lead plaintiff Julie Davis underwent transvaginal mesh surgery and suffered devastating […] [Read More]
 
Investigation by Consumer Reports Sheds Light On Dangerous Medical Devices
Consumer Reports investigates unsafe and untested medical implants on the market, and shares a story of a woman whose transvaginal mesh implants went wrong.  [Read More]
 
Published November 17, 2011 by